Pharmacelera develops proprietary Computer-Aided Drug Design software utilizing Quantum-Mechanics algorithms, Machine Learning, and High-Performance Computing. Its methodology enables improved productivity in pharmaceutical research and development through efficient drug discovery processes.

Pharmacelera

Viewport Meta

IPhone / Mobile Compatible

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

Content Delivery Network

WordPress

Font Awesome

Organization Schema

Joan Bigorra

Alex Widmer

Eugene Shneyderis

Jordi Roses

Ignasi Biosca

Andrea Martinelli

Venkat Reddy

MIGUEL TOVAR

Enric Gibert Codina

CEO and Co-Founder

Enric Herrero

CTO, Co-founder

Life Science Companies With Less Than $10M in Revenue

Spain Companies (Top 10K)

Software Companies with Seed Funding (Top 10K)

Biotechnology Companies With Fewer Than 50 Employees (Top 10K)

Pharmacelera is a company that applies accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) and High-Performance Computing (HPC) to mine an unexploited chemical space and propose molecular candidates that have higher chances to become a drug. The patented computational technology derives from more than 25 years of research at the University of Barcelona and it has been validated in scientific peer-reviewed publications and benchmarking studies performed by our users and customers.

Seed Round - Pharmacelera

Grant - Pharmacelera

Computer and Software Products and Electrical and Scientific Products

Barcelona

Catalonia

Spain

Europe

DNA Encoded Library Market Set to Reach $840 Million in ...

El Govern invierte 5,9 millones en diez 'start up' a través de Avançsa

Generating candidate molecule structure

DFE Pharma expands co-processed portfolio with launch of Pharmacel® sMCC 90

16 Startups Using Quantum Theory To Accelerate Drug Discovery

La ‘start-up’ catalana para buscar moléculas de nuevos fármacos

Machine Learning partnership to accelerate discovery of novel drugs

A virtual screening software package for identifying candidate molecules with diverse chemical structures from various libraries.

Software for navigating and mining ultra-large synthesizable chemical libraries using AI and QM algorithms to find novel hits.

A 3D QSAR software package for building statistical models based on experimental assay data to predict molecular properties.

Tailored drug discovery services provided to biotech companies, big pharma R&D departments, and research institutions.

Free tools for conformer generation and library analysis, supporting drug discovery research.

HTML5

Google Maps API

Bootstrap

Google Analytics

Vimeo

Modernizr

Wordpress

Google Fonts

Apache Server

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 5:33 AM	4430141a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 5:33 AM	b638109f
crunchbase trigger	general	Nov 17, 2024 5:33 AM	bd807d0e
crunchbase profile	general	Nov 17, 2024 5:37 AM	61e6380f
li profile	general	Nov 17, 2024 5:33 AM	788f467c
translate crunchbase fundingrounds	general	Nov 17, 2024 5:59 AM	0e461a0a
peers	general	Nov 17, 2024 5:33 AM	223f52c1
news basic	general	Nov 17, 2024 5:33 AM	5d4a528f
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PHAR

COM:PHARMACELERA

Pharmacelera